Company Quick10K Filing
Aquabounty Technologies
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$2.93 22 $63
10-Q 2019-09-30 Quarter: 2019-09-30
10-Q 2019-06-30 Quarter: 2019-06-30
10-Q 2019-03-31 Quarter: 2019-03-31
10-K 2018-12-31 Annual: 2018-12-31
10-Q 2018-09-30 Quarter: 2018-09-30
10-Q 2018-06-30 Quarter: 2018-06-30
10-Q 2018-03-31 Quarter: 2018-03-31
10-K 2017-12-31 Annual: 2017-12-31
10-Q 2017-09-30 Quarter: 2017-09-30
10-Q 2017-06-30 Quarter: 2017-06-30
10-Q 2017-03-31 Quarter: 2017-03-31
10-K 2016-12-31 Annual: 2016-12-31
8-K 2019-11-05 Earnings, Exhibits
8-K 2019-08-06 Earnings, Exhibits
8-K 2019-06-04 Other Events, Exhibits
8-K 2019-04-30 Earnings, Officers, Shareholder Vote, Exhibits
8-K 2019-04-19 Officers
8-K 2019-04-16 Other Events, Exhibits
8-K 2019-04-04 Enter Agreement, Other Events, Exhibits
8-K 2019-04-04 Other Events, Exhibits
8-K 2019-04-02 Other Events, Exhibits
8-K 2019-03-21 Officers
8-K 2019-03-19 Enter Agreement, Other Events, Exhibits
8-K 2019-03-19 Other Events, Exhibits
8-K 2019-03-18 Other Events, Exhibits
8-K 2019-03-14 Regulation FD, Exhibits
8-K 2019-03-08 Other Events, Exhibits
8-K 2019-03-07 Earnings, Exhibits
8-K 2018-11-28 Officers, Regulation FD, Exhibits
8-K 2018-11-02 Earnings, Exhibits
8-K 2018-10-24 Enter Agreement, Shareholder Rights, Exhibits
8-K 2018-10-16 Enter Agreement, Off-BS Arrangement, Regulation FD, Exhibits
8-K 2018-09-04 Regulation FD, Exhibits
8-K 2018-08-07 Earnings, Exhibits
8-K 2018-05-01 Shareholder Vote
8-K 2018-04-26 Other Events, Exhibits
8-K 2018-01-12 Enter Agreement, Other Events, Exhibits

Aquabounty Technologies Financials

-

AQB Metrics, Comps, Filings


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Quarter)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Quarter)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Assets Liabilities Revenue Gross Profit Net Income EBITDA EV
Arcturus Therapeutics (ARCT) 53,595 44,419 38,065 4,350 0 -6,884 -6,712 32,213
All Soft Gels (ASG) 111,547 56 716 136 55 -1,463 -1,368 111,740
Mercantile Bankshares (MRBK) 115,326 1,055,906 941,527 0 0 9,119 29,812 84,696
Synlogic (SYBX) 282,623 214,945 34,122 2,600 0 -47,969 -46,020 153,623
Inflarx (IFRX) 159,214 7,824 0 0 0 0 -0
Cellect Biotechnology (APOP) 345,599 20,638 0 0 0 0 345,262
Aquabounty Technologies (AQB) 61,340 36,775 7,056 158 23 -11,942 -10,756 55,565
US Gold (USAU) 21,724 8,772 384 0 0 -7,583 -7,147 18,185
1st Franklin Financial (FFC) 3,210 833,128 581,983 0 0 58,119 81,934 -17,598
Pioneer (PIO)
Pet DRx (VETS)
TH Merger Company (CSA) 1,667,207 692,104 529,844 0 0 0 0 1,650,478
Delphi Financial Group (DFP) 8,634,408 6,854,525 0 0 0 0 -0
Alberto-Culver (ACV)
Pelican Financial (PFI)
Apollo Investment (AINV)
Dusa Pharmaceuticals (DUSA) 551,168 41,655 11,248 0 29,530 426 869 522,432
Imagistics (IGI)
Syncora Holdings (SCA)

Balance Sheet ($'000)2017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash25,4737,9914,7184936,8393,5191,0312,9907,63010,401
Accounts Receivable
Inventory1017878172125827376159210
PP&E3,54519,32921,00023,36025,17925,37126,06325,97326,50627,515
Assets28,54926,90825,29623,73231,48828,26026,04327,67133,03036,775
Accounts Payable2673674911,0901,0775267193672791,096
Long-Term Debt
Liabilities3,5903,9554,7185,7515,1544,1604,5144,4375,4737,056
Stockholders' Equity24,95922,95320,57817,98126,33424,10021,52923,23427,55629,718
Income Statement ($'000)2017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Revenue530019481179842
Cost of Revenue47968239
Gross Profit121163
R&D720936861855978881805795663813
SG&A1,3291,1531,5781,8021,4691,9041,9171,6232,1083,210
Tax
Net Income-2,056-2,093-2,446-2,663-2,450-2,781-2,727-2,424-2,764-4,027
Cash Flow ($'000)2017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash Operating-2,504-1,893-2,279-2,425-2,467-2,867-2,135-2,348-2,133-3,073
Cash Investing-457-15,737-1,041-1,811-2,033-985-336-728-456-461
Cash Financing25,110152-12-1210,852547-155,0647,2276,292